Open AccessA durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma
Author(s) -
Zhitao Ying,
Ting He,
Shanzhao Jin,
ChungI Wu,
Wen Zheng,
Ningjing Lin,
Meifeng Tu,
Yun Xie,
Lingyan Ping,
Weiping Liu,
Lijuan Deng,
Yanping Ding,
Xuelian Hu,
Bing Bu,
Xiangjun Lu,
Yuqin Song,
Jun Zhu
Publication year - 2022
Publication title -
chinese journal of cancer research/chinese journal of cancer research
Language(s) - English
Resource type - Journals
eISSN - 1993-0631
pISSN - 1000-9604
DOI - 10.21147/j.issn.1000-9604.2022.01.05
Subject(s) - medicine , cytokine release syndrome , lymphoma , chimeric antigen receptor , cd19 , refractory (planetary science) , adverse effect , regimen , cd28 , oncology , gastroenterology , antigen , cd8 , immunology , immunotherapy , cancer , biology , astrobiology